ライフサイエンスコーパス: short chain

1 inactivating mutations in the gene encoding short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), a u

2 lation was compared with that obtained using short-chain acid groups (MGSA).

3 ain acyl coenzyme A dehydrogenase (MCAD) and short-chain acyl coenzyme A dehydrogenase (SCAD), involv

4 talyze acylations on histones in vitro using short-chain acyl-CoA donors, proving that they are less

5 tissue and systemic levels of carnitine and short chain acylcarnitine, increased beta-oxidation but

6 mitant with an approximately 25% decrease in short-chain acylcarnitine and acetylcarnitine secretion.

7 Increased short-chain acylcarnitines after 1 y were associated wit

8 The highest heritability was for short-chain acylcarnitines, specifically C4 (h(2)=0.66,

9 d with reduced Krebs cycle intermediates and short-chain acylcarnitines, suggesting a global reductio

10 the effects of two representative long- and short-chain AHLs, N-3-(oxododecanoyl)-homoserine lactone

11 Consistent with the observation that short-chain AHLs, unlike oxo-C14-HSL, promote plant grow

12 In this study, a short chain alcohol dehydrogenase/reductase that co-expr

13 s development requires CsgA, a member of the short-chain alcohol dehydrogenase (SCAD) family of prote

14 Mutants of Lactobacillus kefir short-chain alcohol dehydrogenase, used here as ketoredu

15 se II (SCRII) from Candida parapsilosis is a short-chain alcohol dehydrogenase/reductase.

16 Only one short-chain alcohol dehydrogenase/reductases (SDRs), whi

17 proved Tms and product yields of eight other short-chain alcohol dehydrogenases/reductases.

18 hird polymer component, which represents the short-chain alcohol.

19 was investigated, revealing that in dry air, short chain alcohols are more likely adsorbed than long

20 Other short-chain alcohols followed a similar pattern.

21 sine phosphatases, an effect shared by other short-chain alcohols.

22 for the extraction and determination of some short chain aldehydes in different heated edible oil sam

23 R-hydroperoxy-eicosatetraenoic acid into the short-chain aldehydes (5Z)-8-oxo-octenoic acid and (3Z,6

24 cated on residue Cys71 also accumulates with short-chain aldehydes.

25 Yeast-associated volatiles, especially short-chain aliphatic esters, elicited strong antennal r

26 titute the major source and storage site for short-chained aliphatic glucosinolates, long-chained ali

27 ocumenting a methanotroph that can utilize a short-chain alkane as an alternative to methane.

28 SDIMO that seems to be uniquely involved in short-chain alkane metabolism suggests that such metabol

29 d by the symbiotic Cycloclasticus to degrade short-chain alkanes and those of free-living Cycloclasti

30 rtant in many environments where methane and short-chain alkanes co-occur.

31 Analyses of short-chain alkanes in the environment of the Campeche K

32 stead, these symbionts use propane and other short-chain alkanes such as ethane and butane as carbon

33 ed to be entirely distinct from utilizers of short-chain alkanes, and studies of environments exposed

34 il organic material, which forms methane and short-chain alkanes, principally ethane, propane and but

35 The fastest-growing bacteria used short-chain alkanes.

36 Compounds bearing short chain alkanoyl esters led to a fast hydrolysis by

37 ical properties as well as the generation of short chain alpha-dicarbonyl compounds were evaluated.

38 portion of amylose at the expense of reduced short-chain amylopectin.

39 es of 3-hydroxyacyl-coenzyme A dehydrogenase short chain and glutamate dehydrogenase (GDH) were decre

40 bstrates, although it is also active towards short-chain and medium-chain acyl-CoAs, and we have name

41 ains of ascaroside precursors to produce the short-chain ascaroside pheromones.

42 Pivalic acid is a short-chain, branched carboxylic acid used to increase o

43 ally relevant in determining the behavior of short chains, but which saturates rapidly to a length-in

44 an antitumorigenic lipid, and treatment with short-chain C6-ceramide decreased the number of ovarian

45 A diet with reduced content of fermentable short-chain carbohydrates (fermentable oligo-, di-, mono

46 y reduction of fermentable, poorly absorbed, short-chain carbohydrates (fermentable, oligo-, di-, mon

47 ignal transduction system, which responds to short chain carboxylates.

48 Short-chain carboxylates such as acetate are easily prod

49 developed a pipeline to extract and upgrade short-chain carboxylates to esters via membrane electrol

50 e; and 3. reverse beta oxidation to elongate short-chain carboxylates with two carbons into medium-ch

51 ) was exploited for the direct enrichment of short-chain carboxylic (CARBO)-OxPLs, whereas detection

52 ifunctional reactor microbiomes can elongate short-chain carboxylic acids (SCCAs) to medium-chain car

53 A methyl 2-oxoester, with a short chain carrying a naphthalene ring, was found to pr

54 core-shell nanoplatelets was achieved using short-chain Cd ethylhexanoate and sulfur in octadecene a

55 Short-chain chlorinated paraffins (SCCPs) are of concern

56 Accurate quantification of short-chain chlorinated paraffins (SCCPs) poses an excep

57 ocus on collagen IV and its variant, spongin short-chain collagens, of non-bilaterian animal phyla.

58 Other than their established short-chain congeners, polycondensates based on long-cha

59 field samples were within a factor of 5 for short-chain CPs and a factor of 16 for medium-chain CPs

60 dicots and monocots, and showed that all the short-chain CPT genes from tomato (SlCPT1, SlCPT2 and Sl

61 Recently, we identified a short-chain CPT, neryl diphosphate synthase (NDPS1), in

62 Although they belong to the superfamily of short chain dehydrogenase-reductases, the epimerase-acti

63 the identification of missense mutations in short chain dehydrogenase/reductase family 9C, member 7

64 tyrate dehydrogenase (BDH2), a member of the short-chain dehydrogenase (SDR) family of reductases, ca

65 The short-chain dehydrogenase-related protein Ayr1 forms an

66 e enzymes are closely related members of the short-chain dehydrogenase/reductase (SDR) superfamily.

67 We have previously identified a short-chain dehydrogenase/reductase 3 (dhrs3), which sho

68 ains two N-terminal WW domains and a central short-chain dehydrogenase/reductase domain.

69 on by retinol dehydrogenases, members of the short-chain dehydrogenase/reductase family.

70 It is composed of putative short-chain dehydrogenase/reductase Ycf39, encoded by th

71 Interestingly, mycobacterial short chain dehydrogenases/reductases (SDRs) within fami

72 Three genes coding for the NAD(+)-dependent short-chain dehydrogenases/reductases (SDRs) NV10127, NV

73 ly relevant state, and it is well-known that short chain detergents such as octylglucoside are more d

74 ric nanoparticles consisting of cross-linked short chain dextrans, which were modified with desferoxa

75 Higher baseline levels of short-chain dicarboxylacylcarnitine metabolite 3-hydroxy

76 Short-chain dicarboxylacylcarnitine metabolites and aspa

77 s in long-chain acylarnitine metabolites and short-chain dicarboxylacylcarnitines correlated with inc

78 = .01 and .03, respectively), and increased short-chain dicarboxylacylcarnitines glutaryl carnitine,

79 osition pathways of methyl butanoate (MB), a short-chain ester that contains the basic chemical struc

80 -derived citrate or by acetyl-CoA synthetase short-chain family member 2 (ACSS2) from acetate.

81 Alternatively, dietary short-chain FAs (SCFAs) expanded gut T regulatory (Treg)

82 FA) and bacterial overgrowth, which generate short-chain FAs (SCFAs), have been implicated in the gen

83 d the intestinal habitat, allowing increased short chain fatty acid (SCFA) production.

84 sociated with an increase in the levels of a short chain fatty acid (SCFA), butyrate.

85 o differences in gut microbiota diversity or short chain fatty acid production across time or with di

86 Short chain fatty acid production during in vitro fermen

87 This could contribute to reduced short chain fatty acid production in IBD.

88 compensatory protective responses, including short chain fatty acid production.

89 o parallel pathways for the breakdown of the short chain fatty acid propionate in Caenorhabditis eleg

90 ng the activity of the endogenously produced short chain fatty acid propionate in Gi-mediated pathway

91 The short chain fatty acid receptor FFA2 is able to stimulat

92 Analysis of the roles of the short chain fatty acid receptor, free fatty acid 3 recep

93 sodium glucose tranporter-1 (SGLT-1) or the short chain fatty acid sensing receptor FFAR2 (GPR43), f

94 tion of valproate (VPA), a widely prescribed short chain fatty acid with anticonvulsant and anticance

95 Short chain fatty acids (SCFA) are metabolites of intest

96 , plasma and muscle biochemistry, intestinal short chain fatty acids (SCFA), and liver glycogen of tr

97 ed ligand selectivity and sensitivity to the short chain fatty acids (SCFAs) acetate and propionate.

98 (rutin) to identify phenolic metabolites and short chain fatty acids (SCFAs) and compare relative ant

99 Short chain fatty acids (SCFAs) are produced in the gut

100 the induction of T regulatory cells, and the short chain fatty acids (SCFAs) butyrate, propionate and

101 ticle, we demonstrate that dietary fiber and short chain fatty acids (SCFAs) induced the expression o

102 g bacteria, which ferment dietary fiber into short chain fatty acids (SCFAs) known to be important fo

103 lacking intestinal commensals, which supply short chain fatty acids (SCFAs) such as acetate, also ex

104 Among the potential mechanisms, short chain fatty acids (SCFAs), the byproducts of micro

105 eceptor expressed in the kidney, responds to short chain fatty acids (SCFAs).

106 bserved in media containing a combination of short chain fatty acids and glucose and surprisingly, in

107 G protein-coupled receptor that responds to short chain fatty acids and has generated interest as a

108 or 2 in which Gi-mediated signalling by both short chain fatty acids and synthetic agonists was maint

109 nts of the digestion of lipids consisting of short chain fatty acids are higher than those of lipids

110 ated amino acids and nicotinate and depleted short chain fatty acids compared to crude fecal control

111 uman acyl-ACP substrate and readily releases short chain fatty acids from full-length FASN during tur

112 Y-FL-pentanoic-acid staining revealed higher short chain fatty acids levels in the intestine of treat

113 crobial organophosphate degradation produces short chain fatty acids like acetic acid, which induces

114 Fatty Acid Receptor 2 is a GPCR activated by short chain fatty acids produced in high levels in the l

115 Bifidobacterium animalis potentiates colonic short chain fatty acids production and decreases abundan

116 Unlike acetate, short chain fatty acids such as butyrate and propionate

117 nd 65 mug/g, respectively, which, along with short chain fatty acids such as butyric acid (13 mg/g) e

118 6 and C18:3n3) from soya bean oil emulsions; short chain fatty acids were released faster than long c

119 d GPR43, is a G-protein coupled receptor for short chain fatty acids which is involved in the mediati

120 enic glutathione complexes, arsenosugars and short chain fatty acids) were also evaluated to assess t

121 eta cell-expressed GPCR that is activated by short chain fatty acids, particularly acetate.

122 Fermentation end products, in particular the short-chain fatty acid (SCFA) acetate, are believed to b

123 aturing Gradient Gel Electrophoresis (DGGE), short-chain fatty acid (SCFA) and ammonium analyses were

124 iched diet on gut microbiota composition and short-chain fatty acid (SCFA) concentrations in parallel

125 in cell culture by sodium butyrate (NaB), a short-chain fatty acid (SCFA) histone deacetylase (HDAC)

126 P < 0.0001), stool frequency (P = 0.02), and short-chain fatty acid (SCFA) producer Lachnospira [fals

127 nockout mice studies implicate the mammalian short-chain fatty acid (SCFA) receptors, FFAR2 and FFAR3

128 Sodium butyrate (NaBu), a form of short-chain fatty acid (SCFA), acts classically as a pot

129 We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by com

130 high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and

131 main metabolites of the gut microbiota, the short-chain fatty acid acetate.

132 phenylbutyrate (PBA) is a derivative of the short-chain fatty acid butyrate and is approved for trea

133 ost epithelium through the production of the short-chain fatty acid butyrate.

134 Regarding short-chain fatty acid concentrations, prebiotic adminis

135 re observed in stool frequency or form or in short-chain fatty acid concentrations.

136 myeloperoxidase while decreasing total fecal short-chain fatty acid concentrations.

137 ography-mass spectroscopy was used to assess short-chain fatty acid concentrations.

138 cronutrient intake, stool diaries, and fecal short-chain fatty acid concentrations.Patients were rand

139 Furthermore, KGM increased cecal short-chain fatty acid contents, and both KGM and inulin

140 when cultured with butyric acid, a principal short-chain fatty acid in the fermentation metabolites o

141 tions included involvement of amino acid and short-chain fatty acid metabolism pathways.

142 Here, we demonstrate that the short-chain fatty acid n-butyrate, which is secreted in

143 A short-chain fatty acid olfactory receptor Olfr78, recent

144 ring diarrhea are considered to be important short-chain fatty acid producers and may be important fo

145 the therapeutic effects of metformin through short-chain fatty acid production, as well as for potent

146 The short-chain fatty acid profile contributed by dominant g

147 lactate, a slightly acidic pH, and specific short-chain fatty acid profiles, which are high in aceta

148 ylmethionine (SAM) cycle and breaks down the short-chain fatty acid propionic acid, preventing its to

149 colonic secondary bile acids, lower colonic short-chain fatty acid quantities and higher mucosal pro

150 to higher ileal and faecal concentrations of short-chain fatty acids (P<0.05).

151 his study evaluated the properties of faecal short-chain fatty acids (SCFA) as diagnostic biomarkers

152 Short-chain fatty acids (SCFA) were measured by HPLC.

153 Short-chain fatty acids (SCFA), formed by microbial ferm

154 We determined that short-chain fatty acids (SCFA), microbiota-derived bacte

155 ts dietary non-digestible carbohydrates into short-chain fatty acids (SCFA).

156 3, GPR41) and 2 (FFA2, GPR43), for which the short-chain fatty acids (SCFAs) acetate and propionate a

157 tions in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone ma

158 Microbiota-generated fiber-derived short-chain fatty acids (SCFAs) and free fatty acid rece

159 The short-chain fatty acids (SCFAs) are bacterial metabolite

160 KEY POINTS: The short-chain fatty acids (SCFAs) are bacterial metabolite

161 Short-chain fatty acids (SCFAs) are fermentation end pro

162 Short-chain fatty acids (SCFAs) are major products of gu

163 Short-chain fatty acids (SCFAs) are the main products of

164 sobacterium nucleatum produce five different short-chain fatty acids (SCFAs) as metabolic by-products

165 okines (n = 29), fecal calprotectin, and the short-chain fatty acids (SCFAs) butyrate and propionate

166 The effects of luminal short-chain fatty acids (SCFAs) in the foregut are unkno

167 Luminal short-chain fatty acids (SCFAs) influence gut physiologi

168 Short-chain fatty acids (SCFAs) promoted TPH1 transcript

169 metabolic product of commensal bacteria are short-chain fatty acids (SCFAs) that derive from ferment

170 In the gut, anaerobes produce short-chain fatty acids (SCFAs) that modulate immune and

171 insulin and leptin were determined by ELISA; short-chain fatty acids (SCFAs) were measured in stool s

172 n be fermented by colon microbiota producing short-chain fatty acids (SCFAs) with the ability to prev

173 The short-chain fatty acids (SCFAs), acetate, propionate and

174 ABSTRACT: The short-chain fatty acids (SCFAs), acetate, propionate and

175 y GPR43, a receptor for bacterially produced short-chain fatty acids (SCFAs), as a modulator of micro

176 naerobic metabolism, like butyrate and other short-chain fatty acids (SCFAs), induce regulatory T cel

177 Short-chain fatty acids (SCFAs), metabolites produced th

178 We report that short-chain fatty acids (SCFAs), produced by gut microbi

179 plementation of antibiotic-treated mice with short-chain fatty acids (SCFAs), products of microbial m

180 and commensal microbes, such as vitamins and short-chain fatty acids (SCFAs), regulate Treg generatio

181 Microbiota-produced short-chain fatty acids (SCFAs), substrates in the colon

182 Short-chain fatty acids (SCFAs), such as butyrate, produ

183 Short-chain fatty acids (SCFAs), the most abundant micro

184 beneficial bacteria in the colon to produce short-chain fatty acids (SCFAs), which are proposed to h

185 high concentrations of microbially-produced short-chain fatty acids (SCFAs).

186 ural properties, and capability of producing short-chain fatty acids (SCFAs).

187 LP-1) and peptide YY (PYY) when activated by short-chain fatty acids (SCFAs).

188 Levels of the fecal short-chain fatty acids acetate and caproate were reduce

189 The short-chain fatty acids acetate, propionate and butyrate

190 41), are each predominantly activated by the short-chain fatty acids acetate, propionate, and butyrat

191 Short-chain fatty acids affect immune responses and epit

192 Short-chain fatty acids also reduced NF-kappaB activity

193 d long-chain fatty acids exacerbate, whereas short-chain fatty acids ameliorate, autoimmunity in the

194 on of various fermentation products, such as short-chain fatty acids and alcohol.

195 ch diverse environmental cues (e.g., certain short-chain fatty acids and bile acids) inhibit SPI-1 ex

196 ceramides, and an increased incorporation of short-chain fatty acids and dihydroxylated bases into in

197 host features that are affected by microbial short-chain fatty acids and other metabolites.

198 nd redox potential through the production of short-chain fatty acids and that the bacteria adjacent t

199 ipase showed the highest specificity towards short-chain fatty acids butanoic and hexanoic acids, the

200 ut neither AcAc nor the structurally related short-chain fatty acids butyrate and acetate, suppresses

201 erium in the human skin microbiome, produces short-chain fatty acids by glycerol fermentation that ca

202 disaccharides partially restored total fecal short-chain fatty acids from the level significantly rep

203 icrobial and anti-inflammatory activities of short-chain fatty acids have been previously well charac

204 R43 as essential for the biologic effects of short-chain fatty acids in colon.

205 s microbiota-liberated sugars, hormones, and short-chain fatty acids in regulating pathogenicity.

206 imethylamine/trimethylamine N-oxide pathway, short-chain fatty acids pathway, and primary and seconda

207 idium-histolyticum groups, and increased the short-chain fatty acids produced compared to the negativ

208 We show that short-chain fatty acids selectively increase the number

209 1) is a G-protein coupled receptor for which short-chain fatty acids serve as endogenous ligands.

210 D, soluble fiber is the best way to generate short-chain fatty acids such as butyrate, which has anti

211 d, little is known about the contribution of short-chain fatty acids to the adipogenic differentiatio

212 Concentrations of fecal short-chain fatty acids were determined by using gas chr

213 ns were higher in African Americans, whereas short-chain fatty acids were higher in native Africans.

214 Fecal short-chain fatty acids were measured by gas chromatogra

215 costerone, microbiota composition, and cecal short-chain fatty acids were measured.

216 d products that may be used by the host (eg, short-chain fatty acids).

217 under low- or high-fat feeding, particularly short-chain fatty acids, but not hydrogen sulfide, direc

218 tion pathways for corresponding alcohols and short-chain fatty acids, dissimilatory sulfur oxidation,

219 at a group of metabolic by-products, namely, short-chain fatty acids, from bacteria that cause period

220 We determined that short-chain fatty acids, gut microbiota-derived bacteria

221 that supplementation of germ-free mice with short-chain fatty acids, major products of gut bacterial

222 driven with proteins, carbohydrates or other short-chain fatty acids, systems fed with acetic acid re

223 vation of fatty acid receptors for long- and short-chain fatty acids.

224 tors, two pathways that could be affected by short-chain fatty acids.

225 s, including 5-azacytidine, hydroxyurea, and short-chain fatty acids.

226 cose/rhamnose utilisation BMC with different short-chain fatty aldehydes and show that it has activit

227 ng these receptors are those that respond to short-chain free fatty acids of carbon chain length 2-6.

228 nd fructose and lower sucrose content, three short chain fructooligosaccharides were identified in ac

229 e of polymerisation, DP) on the stability of short-chain fructooligosaccharides (sc-FOS) was investig

230 t administration of a highly purified (>95%) short-chain galactooligosaccharide (GOS), designated "RP

231 to form an autocatalytic set, through which short chains grow into longer chains that have particula

232 tissue infections, whereas the generation of short-chain HA can be protective.

233 d during tissue injury, and the functions of short-chain HA that is generated during infection have n

234 ntapeptide and heptaprenyl phosphate (C35-P, short-chain homolog of undecaprenyl phosphate, the endog

235 urs enriched with aromatic side chains among short-chain hydrophilic residues can recognize all sorts

236 of the predicted functional paratopes, with short-chain hydrophilic residues forming the minor porti

237 Typically, individual short-chain IDSs (scIDSs) make the C10, C15, and C20 iso

238 The short-chain isoprenyl diphosphate synthases (IDS) are si

239 a suite of enzymes that generate a series of short chain linear glucans.

240 lipid profile towards increased abundance of short-chain lipids compared to the parent polymyxin-susc

241 A hitherto unobserved requirement of short-chain lipids in activating the transporter support

242 nt a novel analytical method for analysis of short-chain, medium-chain, and long-chain CPs in a singl

243 ized, standardized acylcarnitines (including short-chain, medium-chain, long-chain, dicarboxylic, hyd

244 However, then, how do short-chain molecules spontaneously grow longer?

245 This study suggests that short chain monoglycerides could be used with Tween 80 t

246 region of a ternary phase diagram containing short chain monoglycerides was larger than for di- and t

247 nd safflower oils (60:40) (FlaxSaff; n-6 and short-chain n-3 rich), or 5) high-oleic acid canola oil

248 mixtures are formed in aqueous solutions of short-chain n-alcohols (n </= 10), Tmix increases relati

249 transition temperatures (Tmix) observed when short-chain n-alcohols are incorporated into giant plasm

250 types of lipids, ratios of lipids, types of short-chain n-alcohols, and concentrations of n-alcohols

251 BDD produced mainly short chained OCBPs (dichloromethane, trichloromethane,

252 epeat units within the side chains, allowing short chains of oligo(ethylene glycol) to be solubilised

253 n ILs were significantly more toxic than the short-chain ones, and the anion chain length was shown t

254 yl-CoA and eicosapentaenoyl-CoA) than toward short-chain or aromatic acyl-CoA substrates.

255 n the key compounds (sugars, amino acids and short chain organic acids) in orange juice by NMR and ch

256 etary plant materials into nutrients such as short-chain organic acids (SCOAs).

257 that may be associated with nucleation from short chain pairs.

258 A new strategy for designing a short-chain peptide ligand with high affinity to the Fc

259 bsorbance capacity (ORAC) values of selected short chain peptides were determined using synthetic pep

260 rafiltration showing a high concentration of short chain peptides, which exhibited significantly high

261 Particles functionalized with short-chain peptides are bound to cells through antibody

262 Short-chain perfluorocarboxylates were the dominant frac

263 e, 6:2 and 8:2 fluorotelomer sulfonates, and short chain perfluorocarboxylic acids.

264 Short-chain PFAA behavior in the presence of NAPL, SDS,

265 (PFBA) and perfluoropentanoate (PFPeA), both short-chain PFAAs (<8 carbon chain length), accumulated

266 es; while in European and American countries short chain PFASs were detected, Asian countries still u

267 ton were calculated for six PFASs, including short chain PFASs.

268 Emerging short-chain PFASs showed no temporal changes.

269 , with the congener profile dominated by the short-chain PFCAs (C4-C6).

270 PTEN effects on short-chain phosphoinositide (31)P linewidths and on the

271 f our work extends to other experiments with short-chain phosphoinositides.

272 Among the most common is the use of "short-chain" phosphoinositides, usually dioctanoyl phosp

273 combined with enzyme kinetics with the same short-chain phospholipids to characterize where PI(4,5)P

274 els apparent lack of selectivity for certain short-chain PIPs may require reinterpretation in view of

275 Herein short-chain poly(ethylene glycol) provided optimum extra

276 The polydispersity of relatively short-chain poly(ethylene oxide) [(CH2CH2O2)n; PEO] affe

277 rrel MP, outer membrane protein F (OmpF), in short-chain polybutadiene-poly(ethylene oxide) (PB-PEO)

278 mutant had reduced polyP kinase activity and short chain polyP content and was considerably less viru

279 Trypanosoma brucei) encodes, in contrast, a short chain polyP kinase that localizes to acidocalcisom

280 ontact pathway of the blood-clotting system; short-chain polyP accelerates the common pathway by the

281 t is unknown whether spatial localization of short-chain polyP can accelerate clotting of flowing blo

282 Thus, sub-micromolar concentrations of short-chain polyP can accelerate clotting of flowing blo

283 rowth rate as well as a reduction in PPi and short-chain polyP levels.

284 Short-chain polyphosphate (polyP) is released from plate

285 ly higher levels of pyrophosphate (PPi ) and short-chain polyphosphate (polyP), suggesting accumulati

286 ereas increased amounts of pyrophosphate and short-chain polyphosphates formed after pyrolysis at 250

287 polysulfide, and solid-state transition from short-chain polysulfide to magnesium sulfide occurs at l

288 1-3 for the desaturase enzymes that convert short-chain polyunsaturated fatty acids to long-chain po

289 We demonstrate that short chain precursors produce two-dimensional (2D) nano

290 of the channel do not benefit the exhange of short-chain quinones, for which product dissociation may

291 further suggested that atmospheric inputs of short-chain (replacement) perfluoroalkyl carboxylic acid

292 o dynamic arrays of spinners (self-assembled short chains) rotating in either direction.

293 d indicative of mountainous regions, and the short-chain saturated FAs (SCFA; C4:0-C11:0) - of the lo

294 o degrading large, amorphous structures into short, chain-shaped structures.

295 nverted together with phosphatidylcholine to short-chain SM and diacylglycerol by SM synthase, led to

296 The replacement of PFOA with short-chain substitutes is thus considered the reason fo

297 osis and more severe NASH, based on a set of short-chain TAGs and FFAs.

298 Bran starch had more short chains than had endosperm starch, and was found to

299 layer (SAM) priory chemisorbed on gold, here short-chain thiol derivatives (mercaptopropionic acid, M

300 f long chains of amylopectin was reduced and short chains were increased for IAC202, whereas for IRGA